
Indp stock has been making waves in the market with its unique business model. It's a company that offers a range of products and services, including cloud-based software and managed services.
The company's revenue has been steadily increasing over the years, with a notable spike in 2020. This growth is largely due to the adoption of its cloud-based software by small and medium-sized businesses.
One of the key drivers of Indp stock's success is its focus on innovation. The company has a strong research and development team that continually works on improving its products and services.
Indp stock's management team has a proven track record of success, with a collective experience of over 50 years in the industry.
Additional reading: General Growth Company
You might like: Xpo Logistics Stock Symbol
Financials
INDP's financials reveal a mixed picture. The company's net income has increased 2.6% since last year, but decreased 15.37% since last quarter.
The net income for the past year was -$15.02M, while it was -$5.23M for the last quarter. This fluctuation suggests a volatile financial performance.
Here's a brief summary of INDP's key financial metrics:
It's worth noting that INDP's EPS increased 12.54% since last year, but only 1.07% since the last quarter.
Financials
INDP's financial performance is a mixed bag. The company's net income has increased 2.6% since last year, but decreased 15.37% since the last quarter.
The net income for the past year was -$15.02M, and for the last quarter it was -$5.23M.
Earnings per share (EPS) have also seen an increase, rising 12.54% since last year to -$44.96. However, EPS decreased 1.07% since the last quarter to -$9.10.
Here's a summary of INDP's financial performance:
- Net income: -$15.02M (1Y), -$5.23M (Q2)
- Earnings per share: -$44.96 (1Y), -$9.10 (Q2)
Average Brokerage Rating
The Average Brokerage Rating is a crucial metric to consider when evaluating a stock's potential. It's calculated by averaging the actual recommendations made by brokerage firms, ranging from Strong Buy to Strong Sell.
For Indaptus Therapeutics, Inc. (INDP), the current Average Brokerage Rating (ABR) is a perfect 1.00, indicating a Strong Buy-equivalent recommendation from only one brokerage firm.
This ABR is consistent with the same rating a month ago, also based on a single Strong Buy recommendation. The number of recommendations included in the ABR is just one.
Here's a quick summary of Indaptus Therapeutics' current ABR:
Note how the ABR is a key factor in determining the stock's potential, and how it's essential to consider the number of recommendations included in the calculation.
Stock Performance
Let's take a closer look at the stock performance of INDP.
The past seven days have been tough for INDP, with a decline of 13.7%.
Over the past year, INDP has underperformed the US Biotechs industry, which returned 3.1%.
INDP has also struggled to keep up with the overall market, with a 93.3% decline over the past year compared to the US Market's 16.3% return.
Here's a quick comparison of INDP's performance with the US Biotechs and US Market over the past year:
As you can see, INDP has had a rough ride lately.
Risk and Analysis
The risk associated with Indp stock is a major concern for investors. Shareholders have been substantially diluted in the past year, which can be a red flag.
This dilution is likely due to the company issuing more shares to raise capital, which can lead to a decrease in the value of existing shares. The highly volatile share price over the past 3 months is another warning sign, as it indicates that the company's financial situation is unstable.
The share price's volatility is not just a minor blip on the radar, but rather a significant issue that needs to be addressed.
Worth a look: Simon Company Stock
Risk Analysis
Risk Analysis is crucial when it comes to making informed investment decisions. Shareholders of INDP have been substantially diluted in the past year.
High volatility in the share price is a major concern. Over the past 3 months, INDP's share price has been more volatile than the US market.
INDP's financial health is also a red flag. The company has negative shareholders equity.
The company's price volatility is also worth noting. INDP's average weekly movement is 19.5%, which is significantly higher than the market average of 6.5%.
Here's a comparison of INDP's volatility with industry and market averages:
While INDP's weekly volatility has been stable over the past year, it's still higher than 75% of US stocks.
Broker Rating
Broker Rating is a crucial factor to consider when evaluating a stock's potential. Only one brokerage firm provided a Strong Buy-equivalent recommendation for Indaptus Therapeutics, Inc., resulting in an average brokerage recommendation (ABR) of 1.00. This score is based on a scale of 1 to 5, with 1 being Strong Buy.
The current ABR is identical to the ABR from a month ago, with only one brokerage firm making a Strong Buy recommendation. This consistency suggests that the brokerage community has a clear view on Indaptus Therapeutics, Inc.
Here's a breakdown of the current ABR:
This singular Strong Buy recommendation is a significant factor to consider when evaluating Indaptus Therapeutics, Inc.'s potential.
Community Fair Values
Community Fair Values are a useful tool for investors, allowing them to see what others think a stock is worth.
You can follow the fair value set by others or set your own to get alerts, giving you a sense of the community's sentiment around a particular stock.
This feature can be especially helpful in identifying potential opportunities or red flags, giving you a more comprehensive understanding of a stock's value.
Institutional Holdings
Institutional Holdings provide valuable information about a company's stock, including the number of shares held by institutions.
This data can be used to gauge the volatility and value of a company's stock.
Institutions like Nasdaq track the ownership stake in a company, revealing recent purchases and sales information.
This information can be a useful tool for investors looking to make informed decisions about their investments.
Nasdaq's Institutional Holdings information can give you a better understanding of how institutions are influencing the market.
Indaptus Therapeutics AGM, Sep 29, 2022
At Indaptus Therapeutics' Annual General Meeting on September 29, 2022, the company's share price had been volatile over the past 3 months compared to the US market.
This volatility is notable, as it can affect investor confidence and decision-making.
The company's share price has been a point of interest for investors, and understanding its fluctuations can be crucial for making informed investment decisions.
Indaptus Therapeutics' share price has been a topic of discussion among investors and analysts, and its volatility is something to keep an eye on.
You might like: How Does an Index Understate Volatility in the Equity Market
Frequently Asked Questions
What is the target price for INDP stock?
The target price for INDP stock is $25.00, representing a 253.61% potential increase from its current price. Analysts predict a significant surge in INDP stock value over the next 12 months.
Featured Images: pexels.com


